Viewing StudyNCT00210756

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00210756
Status: COMPLETED
Last Update Posted: 2011-06-10
First Post: 2005-09-13
Brief Title: Pharmacokinetic Pharmacodynamic Study of Epoetin Alfa PROCRIT in Critically Ill Patients
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Critical Illness
Anemia
Keywords:
Name View
critical illness intensive care View
Anemia View
pharmacokinetics View
erythropoetin View
Epoetin alfa View
erythropoetin recombinant View
Critical care View